These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors. Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases. Huang W; Li J; Zhang W; Zhou Y; Xie C; Luo Y; Li Y; Wang J; Li J; Lu W Bioorg Med Chem Lett; 2006 Apr; 16(7):1905-8. PubMed ID: 16434190 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors. Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors. Sun LP; Ma WP; Gao LX; Yang LL; Quan YC; Li J; Piao HR J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1199-204. PubMed ID: 23009604 [TBL] [Abstract][Full Text] [Related]
7. Facile fabrication of promising protein tyrosine phosphatase (PTP) inhibitor entities based on 'clicked' serine/threonine-monosaccharide hybrids. He XP; Deng Q; Gao LX; Li C; Zhang W; Zhou YB; Tang Y; Shi XX; Xie J; Li J; Chen GR; Chen K Bioorg Med Chem; 2011 Jul; 19(13):3892-900. PubMed ID: 21665482 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, and molecular docking study of novel allyl-retrochalcones as a new class of protein tyrosine phosphatase 1B inhibitors. Zhao Y; Cao Y; Chen H; Zhuang F; Wu C; Yoon G; Zhu W; Su Y; Zheng S; Liu Z; Cheon SH Bioorg Med Chem; 2019 Mar; 27(6):963-977. PubMed ID: 30737132 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors. Liu Z; Lee W; Kim SN; Yoon G; Cheon SH Bioorg Med Chem Lett; 2011 Jun; 21(12):3755-8. PubMed ID: 21555221 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I. Meng G; Zheng M; Wang M; Tong J; Ge W; Zhang J; Zheng A; Li J; Gao L; Li J Eur J Med Chem; 2016 Oct; 122():756-769. PubMed ID: 27526040 [TBL] [Abstract][Full Text] [Related]
11. Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitors. Cossy J; Belotti D; Brisson M; Skoko JJ; Wipf P; Lazo JS Bioorg Med Chem; 2006 Sep; 14(18):6283-7. PubMed ID: 16782352 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition. Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909 [TBL] [Abstract][Full Text] [Related]
13. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors. Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959 [TBL] [Abstract][Full Text] [Related]
14. Effective Pharmacophore for CDC25 Phosphatases Enzyme Inhibitors: Newly Synthesized Bromothiazolopyrimidine Derivatives. El-Shahat M; Salama MAM; El-Farargy AF; Ali MM; Ahmed DM Mini Rev Med Chem; 2021; 21(1):118-131. PubMed ID: 32560601 [TBL] [Abstract][Full Text] [Related]
15. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library. Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity. Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and molecular modelling studies of novel 3-acetamido-4-methyl benzoic acid derivatives as inhibitors of protein tyrosine phosphatase 1B. Rakse M; Karthikeyan C; Deora GS; Moorthy NS; Rathore V; Rawat AK; Srivastava AK; Trivedi P Eur J Med Chem; 2013; 70():469-76. PubMed ID: 24185377 [TBL] [Abstract][Full Text] [Related]
18. [Design, synthesis and evaluation of malonic acid-based PTP1B inhibitors]. Du X; Zhang SE; Liu JZ; Nie FL; Ye F; Tian JY; Xiao ZY Yao Xue Xue Bao; 2012 Mar; 47(3):367-73. PubMed ID: 22645761 [TBL] [Abstract][Full Text] [Related]
19. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening. Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450 [TBL] [Abstract][Full Text] [Related]
20. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries. Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]